Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05384873

Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer

Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2025-05-01

180

Participants Needed

1

Research Sites

217 weeks

Total Duration

On this page

Sponsors

F

Fondazione IRCCS Policlinico San Matteo di Pavia

Lead Sponsor

S

San Luigi Gonzaga Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The present study was designed to evaluate the efficacy of the early systematic provision of oral nutritional supplements enriched in immunonutrients in non-small lung cancer patients undergoing immunotherapy and receiving nutritional counseling

CONDITIONS

Official Title

Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed diagnosis of metastatic non-small cell lung cancer (both squamous and non-squamous types)
  • Starting first-line immunotherapy alone or with chemotherapy as chosen by doctors
  • Willing to participate and able to provide written informed consent
  • Able to take oral supplements and receive immunotherapy with or without chemotherapy
  • Eastern Cooperative Oncology Group Performance Status of 2 or less
  • Expected to live 6 months or longer
Not Eligible

You will not qualify if you...

  • Younger than 18 years old
  • Unable to provide informed consent
  • Currently requiring or unable to take oral nutrition due to need for artificial nutrition support or completely compromised food intake

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fondazione IRCCS Policlinico San Matteo

Pavia, Italy

Actively Recruiting

Loading map...

Research Team

R

Riccardo Caccialanza, MD

CONTACT

A

Alessandra Ferrari, PharmD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here